Safety and Efficacy of Tarenflurbil in Subjects With Mild Alzheimer’s Disease: Results From an 18-month Multicenter Phase 3 Trial

First Page		Document Content
Date: 2012-10-18 13:12:18 Tarenflurbil Health Placebo Flurbiprofen Non-steroidal anti-inflammatory drugs Organofluorides Medicine		Safety and Efficacy of Tarenflurbil in Subjects With Mild Alzheimer’s Disease: Results From an 18-month Multicenter Phase 3 Trial Add to Reading List Source URL: www.myriad.com Download Document from Source Website File Size: 1,25 MB Share Document on Facebook

	Pharmacokinetics and efficacy of intraocular flurbiprofen DocID: 1uLR6 - View Document
	SUBMISSION TO THE MCC FOR CONSIDERATION DURING THE 43rd MEETING RECLASSIFICATION OF FLURBIPROFEN FROM: DocID: 14hUU - View Document
	October 20, 2014 To Whom It May Concern: Company Name: Taisho Pharmaceutical Holdings Co., Ltd. DocID: 10nKE - View Document
	OCUFEN® EYE DROPS [flurbiprofen sodium 300 µg per mL] ______________________________________________________________________________________ ® DocID: N5dg - View Document
	NDA[removed]S-026 Page 3 OCUFEN® (flurbiprofen sodium ophthalmic solution, USP) 0.03% DocID: of4j - View Document